I recently received information from Ortho Women's Health & Urology (a Division of Ortho-McNeil-Janssen Pharmaceuticals),  the manufacturers of Elmiron, that a shortage of Elmiron is being anticipated. (Please do not contact me directly regarding the Elmiron shortage-visit the websites listed below or contact OWHU directly via the 800# listed in the last paragraph.) Here is the drug shortage announcement as it was conveyed to me:

On behalf of Ortho Women’s Health & Urology (OWHU), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., we wanted to inform IC patients about a product shortage of ELMIRON® (pentosan polysulfate sodium) 100 mg capsules. ELMIRON® is an oral prescription medication indicated for relief of bladder pain or discomfort associated with interstitial cystitis, a chronic condition of the bladder that affects both women and men.

 

We anticipate this shortage, due to manufacturing delays, could last several months, thus limiting the supply of product available to patients. We are doing everything possible to resolve this shortage and re-establish supply to patients as quickly as possible.

 

We have contacted the U.S. Food and Drug Administration (FDA), pharmacists, physicians, and patient groups to share this news with them directly. Physicians or patients that have questions about this product shortage can contact the OWHU Customer Communications Center at 1-800-526-7736. Physicians seeking information also can visit www.myorthoelmiron360.com; patients can visit www.orthoelmiron.com.